Delivery Order SPE2DB20D3104-SPE2DB24FV8D6

Award Date 7/12/24
Potential Completion Date 7/15/24
Potential Value $2.8K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp (a major pharmaceutical distributor) has a ceiling value of $5,957.07. The delivery order is for the drug VEMLIDY 25 MG TABLET UU 30S, with a completion date of September 21, 2022. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the delivery of VEMLIDY 25 MG TABLET UU 30S. The $5,716.99 firm fixed-price delivery order contract has a period of performance through February 5, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of VEMLIDY 25 MG TABLET UU 30S. The $17,342.53 firm fixed-price delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which runs through November 2026. This IDC enables efficient government procurement of a...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a delivery order valued at $1,985.54. The award is for the supply of VEMLIDY 25 MG TABLET UU 30S, a pharmaceutical product, to the Defense Logistics Agency (DLA), a defense agency. The contract has an ultimate completion date of March 18, 2025 and is a firm fixed-price contract. The award is not designated as a set-aside contract. Amerisourcebergen holds a significant Indefinite Delivery Contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,357.98 firm fixed-price delivery order contract is for the supply of VEMLIDY 25 MG TABLET, a specific pharmaceutical product. The contract has an ultimate completion date of January 23, 2024 and is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, which does not have a set-aside designation, is for the delivery of VEMLIDY 25 MG TABLET in quantities of 30 tablets. The $6,441.91 Firm Fixed Price contract has an ultimate completion date of April 30, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,250.28 delivery order contract is for the supply of VEMLIDY 25 MG TABLET, a pharmaceutical product. The contract is a firm fixed-price, non-set-aside award with an ultimate completion date of August 24, 2022. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award to Amerisourcebergen Drug Corp is for the delivery of VEMLIDY 25 MG TABLET UU 30S, a pharmaceutical product, to the Defense Logistics Agency (DLA) for a ceiling value of $2,828.40. The contract has a January 3, 2025 ultimate completion date and is a Firm Fixed Price Delivery Order. There is no set-aside designation mentioned. Amerisourcebergen, a major pharmaceutical distributor and healthcare solutions provider, holds a significant Indefinite Delivery Contract...
This federal contract award is for the delivery of VEMLIDY 25 MG TABLET UU 30S, a pharmaceutical product, to the Medical Supply Chain division of the Defense Logistics Agency (DLA). The contract, valued at $12,904.04, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of April 4, 2025. No set-aside designation was used for this...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $52,611.95, is a firm fixed-price delivery order for the supply of VEMLIDY 25 MG TABLET medical products. The contract has an ultimate completion date of February 18, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
  • SPE2DB20D3104
    Indefinite Delivery Contract
  • SPE2DB20D3104-SPE2DB24FV8D6
    Delivery Order

This federal contract award is for the delivery of VEMLIDY 25 MG TABLET UU 30S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $2,805.33 Firm Fixed Price contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on July 12, 2024, with a completion date of July 15, 2024. There was no set-aside designation for this award.

AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation through May 2024, covering similar medical products and prescription drugs.

Generated 2/27/25, 10:44 AM